"Global Soft Tissue Sarcomas Treatment Market Size, Share, and Trends Analysis Report—Industry Overview and Forecast to 2032 Executive Summary: The global Soft Tissue Sarcomas Treatment market size was valued at USD 1.52 billion in 2024 and is projected to reach USD 2.51 billion by 2032, with a CAGR of 6.49% during the forecast period of 2025 to 2032. Soft Tissue Sarcomas Treatment...

"Executive Summary Chronic Eosinophilic Leukemia (CEL) Market Size, Share, and Competitive Landscape The geriatric population is expected to increase the patient population globally, which boots the market in the forecast period. According to the WHO, the global elderly population is expected to reach around 2 billion by 2050 from 617 million in 2015. An exceptional Chronic Eosinophilic...

"Executive Summary Neuroendocrine Tumors Market : The global neuroendocrine tumors market size was valued at USD 3.56 billion in 2024 and is expected to reach USD 7.87 billion by 2032, at a CAGR of 10.4% during the forecast period DBMR team is focused on understanding client’s businesses and its needs so that the finest market research report is...

Rare Disease Drugs Market Overview   The global Rare Disease Drugs Market size is expected to grow from USD 179.5 billion in 2025 to USD 364.1 billion by 2033, expanding at a CAGR of 9.6% during the forecast period. Rare diseases, defined by their low prevalence, often lack sufficient treatment options and are frequently overlooked in traditional drug development pipelines....

Bone cancer, while relatively rare compared to other malignancies, represents a devastating diagnosis that profoundly impacts patients and their families. This group of cancers, which can originate in the bone (primary bone cancer) or spread to the bone from other parts of the body (secondary or metastatic bone cancer), presents significant challenges in diagnosis, treatment, and patient...